Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Novo Nordisk's game-changing oral diabetes drug clears Phase II Will GLP market growth save Novo's Victoza from Lilly's new Trulicity?
In 2024, it repositioned its product line to cater to people taking GLP-1 drugs for weight loss, hoping to attract customers and grow its business
doi: 10.1111/dom.12685 22 FismanEZTenenbaumA
To obtain two subgroups of patients that were comparable, we used propensity score (PS) matching (PSM) with the nearest neighbor method and the logit distance, and a maximum caliper 0.5% SD of PS
US$ 22.66
US$ 29.61
US$ 24.25
US$ 27.65
US$ 25.43
US$ 23.90
US$ 29.20
US$ 25.09
US$ 24.87
US$ 23.90
